Topa, Antonietta (2020) Investigation of clinical and pathogenic heterogeneity in Chronic Inflammatory Demyelinating Polyneuropathy. [Tesi di dottorato]

[img]
Preview
Text
tesi_dottorato_topa_antonietta.pdf

Download (1MB) | Preview
[error in script] [error in script]
Item Type: Tesi di dottorato
Lingua: English
Title: Investigation of clinical and pathogenic heterogeneity in Chronic Inflammatory Demyelinating Polyneuropathy
Creators:
CreatorsEmail
Topa, Antoniettaanto.topa87@gmail.com
Date: 18 June 2020
Number of Pages: 69
Institution: Università degli Studi di Napoli Federico II
Department: Neuroscienze e Scienze Riproduttive ed Odontostomatologiche
Dottorato: Neuroscienze
Ciclo di dottorato: 32
Coordinatore del Corso di dottorato:
nomeemail
Taglialatela, Mauriziomtaglial@unina.it
Tutor:
nomeemail
Santoro, LucioUNSPECIFIED
Date: 18 June 2020
Number of Pages: 69
Uncontrolled Keywords: CIDP
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/26 - Neurologia
Date Deposited: 05 Jun 2020 16:09
Last Modified: 28 Oct 2021 12:24
URI: http://www.fedoa.unina.it/id/eprint/13252

Abstract

My aim during the last three years was to create a detailed database of CIDP patients, in order to analyse the data collected in a retrospective manner and to take part to national projects on the disease. In fact, since aspects of CIDP are still unsolved, such as clinical variability, pathogenesis, prognostic factors, outcome measures and response to treatment, and considering that CIDP is a rare disease, a nation-wide collaboration is indispensable. In Section 1 I will describe the clinical and epidemiological features of CIDP patients who referred, in the last 15 years, to our Centre of Neuromuscular Disease at University Federico II of Naples and that I selected among all the patients with disimmune diseases of peripheral nervous system. In Section 2 I will summarise the preliminary conclusions derived from the creation of a web-based national database promoted by the Humanitas Institute that involved more than 500 patients, among which 51 come from our Neuromuscular Centre in Naples. Section 3 is dedicated to the pathogenesis, in particular to the emerging role of antibodies against paranodal proteins in the determination of specific morphologic alterations and clinical phenotypes. In particular, I will speculate on the pathogenesis of CIDP with antibodies against Neurofascin 155. Then I will report the results derived from our collaboration with the IRCCS Mondino Foundation, Pavia, Italy, which analyzed the sera from different national centres, including our centre, in order to identify and characterize the anti-nodal and paranodal antibodies incidence and their correlation with phenotypic aspects in a large cohort of patients.

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item